The Therapeutic Goods Administration approval comes as a result of positive safety and efficacy outcomes from three prospective clinical trials -- the Patient Activated Controlled Expansion I and II studies and ASPIRE -- led by Australian plastic surgeon Tony Connell, MD, FRACS.
http://www.sys-con.com/node/2864446
http://www.sys-con.com/node/2864446
No comments:
Post a Comment